Core Viewpoint - BlackRock TCP Capital Corp. is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding the valuation of its investments and the quality of its portfolio [1] Group 1: Lawsuit Details - The lawsuit claims that from November 6, 2024, to January 23, 2026, the company failed to disclose that its investments were not being valued appropriately [1] - Allegations include ineffective portfolio restructuring efforts that did not resolve challenged credits or improve portfolio quality [1] - The complaint states that the company's unrealized losses were understated, leading to an overstated Net Asset Value (NAV) [1] Group 2: Investor Participation - Investors who suffered losses in BlackRock TCP Capital Corp. are encouraged to contact the Law Offices of Howard G. Smith to participate in the class action lawsuit [1] - The deadline for potential lead plaintiffs to join the lawsuit is April 6, 2026 [1] - Interested investors can retain counsel or remain absent members of the class action without taking immediate action [1]

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against F5, Inc. due to allegations of misleading statements regarding the security of its BIG-IP products, which resulted in significant financial losses for investors [1][2]. Group 1: Allegations and Impact - The lawsuit claims that F5 executives misled the market about the security of its core products, particularly after a sophisticated nation-state threat actor allegedly accessed F5's systems and exfiltrated sensitive source code [2][9]. - Following the revelation of the security breach in October 2025, F5's market value dropped by over $2 billion due to a significant decline in stock price [2][9]. - The breach was disclosed on October 15, 2025, revealing that the threat actor had maintained long-term access to F5's systems, which included critical product development environments [9]. Group 2: Financial Performance and Guidance - F5's disappointing fourth-quarter fiscal 2025 results, released on October 27, 2025, indicated a significant reduction in expected sales and renewals, elongated sales cycles, and increased expenses due to ongoing remediation efforts [9]. - The company announced that the BIG-IP product, which was the subject of the breach, is its highest revenue-generating product, and the stock price fell by $22.83, or 7%, the following day [9]. - The revenue guidance for fiscal 2026 was significantly below market expectations, attributed largely to the impact of the security breach [9]. Group 3: Legal Proceedings and Next Steps - The lead plaintiff deadline for the class action lawsuit is set for February 17, 2026, and the class period is defined from October 28, 2024, to October 27, 2025 [5][7]. - Hagens Berman is actively investigating the claims and advising investors who suffered losses during the class period [4][7].

Core Viewpoint - A class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for alleged securities fraud affecting investors between August 3, 2023, and December 26, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Ultragenyx made misleading statements regarding the efficacy of setrusumab, particularly that while it increases bone density, it does not correlate with a decrease in annualized fracture rates [1] - On December 29, 2025, Ultragenyx announced that its Phase III Orbit and Cosmic Studies did not achieve statistical significance in reducing annualized clinical fracture rates compared to placebo or bisphosphonates [1] - Following the announcement, Ultragenyx's stock price plummeted from $34.19 per share on December 26, 2025, to $19.72 per share on December 29, 2025, marking a decline of approximately 42.32% in just one day [1] Group 2: Investor Information - Investors who suffered losses during the relevant time frame have until April 6, 2026, to request to be appointed as lead plaintiff in the lawsuit [1] - Class members may be entitled to compensation without any out-of-pocket costs or fees [1] - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1]

Lost Money on Richtech Robotics Inc.(RR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky [Accessibility Statement] Skip NavigationNEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ: RR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Richtech investors who were adversely affected by alleged securities fraud between January 27, 2026 and Janu ...

March 9, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ARDT [Accessibility Statement] Skip NavigationNEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November ...

Lost Money on Oracle Corporation(ORCL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky [Accessibility Statement] Skip NavigationNEW YORK, Feb. 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Oracle investors who were adversely affected by alleged securities fraud between June 12, 2025 and December 16, 2025 ...

Core Viewpoint - Varonis Systems, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 4, 2025, and October 28, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Varonis provided misleading statements about its ability to convert its customer base to its SaaS offering, which led to a significant reduction in annual recurring revenue (ARR) growth potential [1] - On October 28, 2025, Varonis reported third-quarter financial results that significantly missed ARR expectations and lowered its full-year guidance, attributing this to weaker than expected renewals and conversions in its subscription business [1] - Following the announcement, Varonis' stock price plummeted from $63.00 per share to $32.34 per share on October 29, 2025, marking a decline of approximately 48.67% in just one day [1] Group 2: Investor Actions - Investors who suffered losses during the specified timeframe have until March 9, 2026, to request appointment as lead plaintiff in the lawsuit [1] - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [1] Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [1]

Group 1 - The article discusses a class action securities lawsuit against Plug Power Inc. for alleged securities fraud occurring between January 17, 2025, and November 13, 2025 [1] - The lawsuit claims that Plug Power's management made false statements regarding the availability of funds from the U.S. Department of Energy's Loan Program and the company's ability to construct necessary hydrogen production facilities [1] - It is alleged that these misrepresentations led to a pivot towards less ambitious projects, impacting the company's commercial prospects [1] Group 2 - Investors affected by the alleged fraud have until April 3, 2026, to request to be appointed as lead plaintiff in the case [1] - Participation in the lawsuit does not require any out-of-pocket costs for class members, as compensation may be available without fees [1] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [1]

Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Denha v. BellRing Brands, Inc., No. 1:26-cv-00575 [2]. - Investors have until March 23, 2026, to request to be appointed to lead the case [2]. Group 2: Company Background - BellRing Brands develops, markets, and sells "convenient nutrition" products, primarily ready-to-drink protein shakes under the Premier Protein brand [3]. - The company previously claimed that its sales growth was due to increased consumer demand and various positive factors, while downplaying competitive pressures [3]. Group 3: Stock Performance and Impact - On May 6, 2025, BellRing's CFO indicated that several key retailers had reduced their inventory levels, leading to a projected mid-single-digit headwind for Q3 growth, resulting in a stock price drop of $14.88 per share, or 19% [4]. - Following the announcement of narrowed fiscal year 2025 sales outlook on August 4, 2025, the stock dropped by $17.46 per share, nearly 33%, the next day [5][6].

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...